...
首页> 外文期刊>American Journal of Cancer Research >MiR-449a suppresses cell invasion by inhibiting MAP2K1 in non-small cell lung cancer
【24h】

MiR-449a suppresses cell invasion by inhibiting MAP2K1 in non-small cell lung cancer

机译:MiR-449a通过抑制MAP2K1抑制非小细胞肺癌的细胞侵袭

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Increasing evidence reveals that deregulation of miRNAs contributes to carcinogenesis of the human non-small cell lung cancer (NSCLC). Our study discovered that the expression of miR-449a was markedly decreased in NSCLC cells with high metastatic capacity and tissues of positive lymph node metastasis. Moreover, our results showed that miR-449a could act as a tumor suppressor by inhibiting the invasion of NSCLC cells in vitro and in vivo. Mechanistically, miR-449a inhibited the expression of MAP2K1 by direct targeting its 3’UTR, and regulated the activity of MEK1/ERK1/2/c-Jun pathway through an auto-regulatory feedback loop. Furthermore, the histone methylation mediated the decreased expression of miR-449a through SUZ12. Taken together, the novel connection between miR-449a and MAP2K1 demonstrated here provided a new, potential therapeutic target for the treatment of non-small cell lung cancer.
机译:越来越多的证据表明,miRNA的失控有助于人类非小细胞肺癌(NSCLC)的癌变。我们的研究发现,在具有高转移能力的NSCLC细胞和阳性淋巴结转移组织中,miR-449a的表达明显降低。此外,我们的结果表明,miR-449a可以通过在体外和体内抑制NSCLC细胞的侵袭而起到抑癌作用。从机制上讲,miR-449a通过直接靶向3'UTR来抑制MAP2K1的表达,并通过自动调节反馈回路调节MEK1 / ERK1 / 2 / c-Jun途径的活性。此外,组蛋白甲基化通过SUZ12介导了miR-449a表达的降低。综上所述,miR-449a和MAP2K1之间的新型连接在此处证明为非小细胞肺癌的治疗提供了新的潜在治疗靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号